Diagnosis and Management of Severe Pulmonary and Extrapulmonary Tuberculosis in Critically Ill Patients: A Mini Review for Clinicians

Overview

Journal World J Crit Care Med

Publisher Baishideng Publishing Group

Specialty Critical Care

Date 2024 Jun 10

PMID 38855275

Authors

Dominic Ti Ming Tan

Kay Choong See

Affiliations

Soon will be listed here.

Abstract

Among critically ill patients, severe pulmonary and extrapulmonary tuberculosis has high morbidity and mortality. Yet, it is a diagnostic challenge given its nonspecific clinical symptoms and signs in early stages of the disease. In addition, management of severe pulmonary and extrapulmonary tuberculosis is complicated given the high risk of drug-drug interactions, drug-disease interactions, and adverse drug reactions. To help clinicians acquire an up-to-date approach to severe tuberculosis, this paper will provide a narrative review of contemporary diagnosis and management of severe pulmonary and extrapulmonary tuberculosis in critically ill patients.

References

Agarwal R, Gupta D, Aggarwal A, Behera D, Jindal S . Experience with ARDS caused by tuberculosis in a respiratory intensive care unit. Intensive Care Med. 2005; 31(9):1284-7. PMC: 7094910. DOI: 10.1007/s00134-005-2721-2. View

Thwaites G, van Toorn R, Schoeman J . Tuberculous meningitis: more questions, still too few answers. Lancet Neurol. 2013; 12(10):999-1010. DOI: 10.1016/S1474-4422(13)70168-6. View

Critchley J, Young F, Orton L, Garner P . Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2013; 13(3):223-37. DOI: 10.1016/S1473-3099(12)70321-3. View

Duro R, Dias P, Ferreira A, Xerinda S, Lima Alves C, Sarmento A . Severe Tuberculosis Requiring Intensive Care: A Descriptive Analysis. Crit Care Res Pract. 2017; 2017:9535463. PMC: 5303839. DOI: 10.1155/2017/9535463. View

Figaji A, Fieggen A, Peter J . Endoscopic third ventriculostomy in tuberculous meningitis. Childs Nerv Syst. 2003; 19(4):217-25. DOI: 10.1007/s00381-003-0730-4. View

Kent S, Crowe S, Yung A, Lucas C, Mijch A . Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993; 17(6):987-94. DOI: 10.1093/clinids/17.6.987. View

Schutz C, Davis A, Sossen B, Lai R, Ntsekhe M, Harley Y . Corticosteroids as an adjunct to tuberculosis therapy. Expert Rev Respir Med. 2018; 12(10):881-891. PMC: 6293474. DOI: 10.1080/17476348.2018.1515628. View

Prasad K, Singh M, Ryan H . Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016; 4:CD002244. PMC: 4916936. DOI: 10.1002/14651858.CD002244.pub4. View

Saukkonen J, Cohn D, Jasmer R, Schenker S, Jereb J, Nolan C . An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006; 174(8):935-52. DOI: 10.1164/rccm.200510-1666ST. View

10.

Thomas L, Chacko B, Jupudi S, Mathuram A, George T, Gunasekaran K . Clinical Profile and Outcome of Critically Ill Patients with Tuberculosis. Indian J Crit Care Med. 2021; 25(1):21-28. PMC: 7874288. DOI: 10.5005/jp-journals-10071-23503. View

11.

Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger C, Schumacher S . Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. 2018; 8:CD012768. PMC: 6513199. DOI: 10.1002/14651858.CD012768.pub2. View

12.

Tappero J, Bradford W, Agerton T, Hopewell P, Reingold A, Lockman S . Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin Infect Dis. 2005; 41(4):461-9. DOI: 10.1086/431984. View

13.

Sudarsan T, Thomas L, Samprathi A, Chacko B, Mathuram A, George T . Tuberculous ARDS is associated with worse outcome when compared with non-tuberculous infectious ARDS. J Crit Care. 2020; 61:138-143. DOI: 10.1016/j.jcrc.2020.10.015. View

14.

Wang M, Luo L, Zhang Y, Liu X, Liu L, He J . Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis. BMC Pulm Med. 2019; 19(1):200. PMC: 6833188. DOI: 10.1186/s12890-019-0966-8. View

15.

Ferreira M, Neves C, de Souza A, Beraldi-Magalhaes F, Migliori G, Kritski A . Predictors of mortality among intensive care unit patients coinfected with tuberculosis and HIV. J Bras Pneumol. 2018; 44(2):118-124. PMC: 6044649. DOI: 10.1590/s1806-37562017000000316. View

16.

Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger C . Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021; 1:CD012768. PMC: 8078545. DOI: 10.1002/14651858.CD012768.pub3. View

17.

Lawn S, Wilkinson R . ART and prevention of HIV-associated tuberculosis. Lancet HIV. 2015; 2(6):e221-2. DOI: 10.1016/S2352-3018(15)00081-8. View

18.

Aso H, Kondoh Y, Taniguchi H, Kimura T, Nishiyama O, Kato K . Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequelae. Intern Med. 2010; 49(19):2077-83. DOI: 10.2169/internalmedicine.49.3749. View

19.

Mase S, Ramsay A, Ng V, Henry M, Hopewell P, Cunningham J . Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis. 2007; 11(5):485-95. View

20.

Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas M, Lode H . Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J. 2006; 27(6):1223-8. DOI: 10.1183/09031936.06.00088105. View